An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT03289182 · COMPLETED

Trial details

NCT number: NCT03289182
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Lymphoma, Non-Hodgkin Leukemia, Lymphocytic, Chronic, B-Cell

Start date: 2017-09-15
Primary completion: 2020-10-27
Enrollment: 701

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.